Skip to main content
Log in

Trial of amifostine in autologous stem cell transplant

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Spencer A, Horvath N, Gibson J, Prince HM, Hermann R, Bashford J et al. Prospective randomized trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphelan conditioned autologous stem cell transplantation. Bone Marrow Transplant 2005; 35: 971–977.

    Article  CAS  Google Scholar 

  2. Thieblemont C, Dumontet C, Saad H, Roche N, Bouafia F, Arnaud P et al. Amifostine reduces mucosal damage after high dose melphelan conditioning and autologous peripheral blood progenitor cell transplantation in patients with multiple myeloma. Bone Marrow transplant 2002; 30: 769–775.

    Article  CAS  Google Scholar 

  3. Philips GL, Meisenberg B, Reece DE, Adams VR, Badros A, Brunner J et al. Amifostine and autologous hematopoietic stem cell support of escalating-dose melphelan: a phase 1 study. Biol Blood Marrow Transplant 2004; 10: 473–483.

    Article  Google Scholar 

  4. Capelli D, Santini G, De Souza C, Poloni A, Marino G, Montanari M et al. Amifostine can reduce mucosal damage after high-dose melphelan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study. Br J Hematol 2000; 110: 300–307.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sastry, P., Bhagwat, R., Biswas, G. et al. Trial of amifostine in autologous stem cell transplant. Bone Marrow Transplant 37, 117–118 (2006). https://doi.org/10.1038/sj.bmt.1705204

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705204

  • Springer Nature Limited

Navigation